Ritivel

Every pharma founder knows the regulatory affairs nightmare — months of review, one FDA redline, and you're back at square one. Ritivel's platform uses AI to catch compliance gaps and flag inconsistencies before submission, so you're not playing whack-a-mole with amendments. It's the unsexy infrastructure that makes or breaks a $12B drug launch. Honestly, the wild part is this didn't exist sooner.